Skip to Main Content

Advertisement

American Association for Cancer Research Logo
header search
Search
Advanced Search
Skip Nav Destination

Issues

Volume 1, Issue 11
1 November 1995
Clinical Cancer Research Cover Image for Volume 1, Issue 11
All Issues
ISSN 1078-0432
EISSN 1557-3265
Issue Sections

Minireview

Preclinical studies of water-insoluble camptothecin congeners: cytotoxicity, development of resistance, and combination treatments.
P Pantazis
View articletitled, Preclinical studies of water-insoluble camptothecin congeners: cytotoxicity, development of resistance, and combination treatments.
Open the PDF for in another window

Advances in Brief

Telomerase activity in preneoplastic and neoplastic gastric and colorectal lesions.
H Tahara; H Kuniyasu; H Yokozaki; W Yasui; J W Shay; T Ide; E Tahara
View articletitled, Telomerase activity in preneoplastic and neoplastic gastric and colorectal lesions.
Open the PDF for in another window
Human glioma cells overexpress receptors for interleukin 13 and are extremely sensitive to a novel chimeric protein composed of interleukin 13 and pseudomonas exotoxin.
W Debinski; N I Obiri; S K Powers; I Pastan; R K Puri
View articletitled, Human glioma cells overexpress receptors for interleukin 13 and are extremely sensitive to a novel chimeric protein composed of interleukin 13 and pseudomonas exotoxin.
Open the PDF for in another window

Research Articles

Phase Ia trial of murine immunoglobulin A antitransferrin receptor antibody 42/6.
D Brooks; C Taylor; B Dos Santos; H Linden; A Houghton; T T Hecht; S Kornfeld; R Taetle
View articletitled, Phase Ia trial of murine immunoglobulin A antitransferrin receptor antibody 42/6.
Open the PDF for in another window
Rapidly cycled courses of high-dose alkylating agents supported by filgrastim and peripheral blood progenitor cells in patients with metastatic breast cancer.
L Vahdat; G Raptis; D Fennelly; N Hamilton; L Reich; A Tiersten; M Harrison; C Hudis; M Moore; T J Yao; Larry Norton; John Crown
View articletitled, Rapidly cycled courses of high-dose alkylating agents supported by filgrastim and peripheral blood progenitor cells in patients with metastatic breast cancer.
Open the PDF for in another window
Clinical pharmacokinetic and pharmacodynamic studies with the nonclassical antifolate thymidylate synthase inhibitor 3, 4-dihydro-2-amino-6-methyl-4-oxo-5-(4-pyridylthio)-quinazolone dihydrochloride (AG337) given by 24-hour continuous intravenous infusion.
I Rafi; G A Taylor; J A Calvete; A V Boddy; K Balmanno; N Bailey; M Lind; A H Calvert; S Webber; R C Jackson
View articletitled, Clinical pharmacokinetic and pharmacodynamic studies with the nonclassical antifolate thymidylate synthase inhibitor 3, 4-dihydro-2-amino-6-methyl-4-oxo-5-(4-pyridylthio)-quinazolone dihydrochloride (AG337) given by 24-hour continuous intravenous infusion.
Open the PDF for in another window
Immune responses in patients with T-cell lymphoma treated with an anti-idiotype antibody mimicking a highly restricted T-cell antigen.
K A Foon; A R Oseroff; L Vaickus; S J Greenberg; D Russell; Z Bernstein; S Pincus; H Köhler; B K Seon; E Tahaoglu
View articletitled, Immune responses in patients with T-cell lymphoma treated with an anti-idiotype antibody mimicking a highly restricted T-cell antigen.
Open the PDF for in another window
p53 nuclear protein expression is an independent prognostic marker in clinically localized prostate cancer patients undergoing radical prostatectomy.
J J Bauer; I A Sesterhenn; K F Mostofi; D G McLeod; S Srivastava; J W Moul
View articletitled, p53 nuclear protein expression is an independent prognostic marker in clinically localized prostate cancer patients undergoing radical prostatectomy.
Open the PDF for in another window
Expression of the multidrug resistance-associated protein (MRP) gene in human cancers.
K Nooter; A M Westerman; M J Flens; G J Zaman; R J Scheper; K E van Wingerden; H Burger; R Oostrum; T Boersma; P Sonneveld
View articletitled, Expression of the multidrug resistance-associated protein (MRP) gene in human cancers.
Open the PDF for in another window
Biological efficacy of a chimeric antibody to the epidermal growth factor receptor in a human tumor xenograft model.
N I Goldstein; M Prewett; K Zuklys; P Rockwell; J Mendelsohn
View articletitled, Biological efficacy of a chimeric antibody to the epidermal growth factor receptor in a human tumor xenograft model.
Open the PDF for in another window
Monocyte-mediated lysis of acute myeloid leukemia cells in the presence of the bispecific antibody 251 x 22 (anti-CD33 x anti-CD64).
J Chen; J H Zhou; E D Ball
View articletitled, Monocyte-mediated lysis of acute myeloid leukemia cells in the presence of the bispecific antibody 251 x 22 (anti-CD33 x anti-CD64).
Open the PDF for in another window
Alterations in T cell receptor and signal transduction molecules in melanoma patients.
A H Zea; B D Curti; D L Longo; W G Alvord; S L Strobl; H Mizoguchi; S P Creekmore; J J O'Shea; G C Powers; W J Urba
View articletitled, Alterations in T cell receptor and signal transduction molecules in melanoma patients.
Open the PDF for in another window
In vitro synergism between 5-fluorouracil and natural beta interferon in human colon carcinoma cells.
A Guglielmi; C Aschele; A Mori; C Baldo; P Russo; D Debernardis; M Valenti; S Bruno; M Taverna; R Rosso
View articletitled, In vitro synergism between 5-fluorouracil and natural beta interferon in human colon carcinoma cells.
Open the PDF for in another window
Effects of 9-aminocamptothecin on newly synthesized DNA in patient bone marrow samples.
F Geoffroy; W Dahut; C H Takimoto; J L Grem
View articletitled, Effects of 9-aminocamptothecin on newly synthesized DNA in patient bone marrow samples.
Open the PDF for in another window
Involvement of human interleukin 6 in experimental cachexia induced by a human uterine cervical carcinoma xenograft.
S Tamura; K F Ouchi; K Mori; M Endo; T Matsumoto; H Eda; Y Tanaka; H Ishitsuka; H Tokita; K Yamaguchi
View articletitled, Involvement of human interleukin 6 in experimental cachexia induced by a human uterine cervical carcinoma xenograft.
Open the PDF for in another window
Retroviral transfer of a bacterial alkyltransferase gene into murine bone marrow protects against chloroethylnitrosourea cytotoxicity.
L C Harris; U K Marathi; C C Edwards; P J Houghton; D K Srivastava; E F Vanin; B P Sorrentino; T P Brent
View articletitled, Retroviral transfer of a bacterial alkyltransferase gene into murine bone marrow protects against chloroethylnitrosourea cytotoxicity.
Open the PDF for in another window
Preclinical toxicity of liposome-incorporated annamycin: selective bone marrow toxicity with lack of cardiotoxicity.
Y Zou; W Priebe; L C Stephens; R Perez-Soler
View articletitled, Preclinical toxicity of liposome-incorporated annamycin: selective bone marrow toxicity with lack of cardiotoxicity.
Open the PDF for in another window
Predictive and prognostic markers in a series of patients with head and neck squamous cell invasive carcinoma treated with concurrent chemoradiation therapy.
G Gasparini; P Bevilacqua; E Bonoldi; A Testolin; A Galassi; P Verderio; P Boracchi; R B Guglielmi; F Pezzella
View articletitled, Predictive and prognostic markers in a series of patients with head and neck squamous cell invasive carcinoma treated with concurrent chemoradiation therapy.
Open the PDF for in another window
Loss of heterozygosity at 7q31 is a frequent and early event in prostate cancer.
A Latil; O Cussenot; G Fournier; J C Baron; R Lidereau
View articletitled, Loss of heterozygosity at 7q31 is a frequent and early event in prostate cancer.
Open the PDF for in another window
Expression of topoisomerase II, bcl-2, and p53 in three human brain tumor cell lines and their possible relationship to intrinsic resistance to etoposide.
C E Herzog; L A Zwelling; A McWatters; E S Kleinerman
View articletitled, Expression of topoisomerase II, bcl-2, and p53 in three human brain tumor cell lines and their possible relationship to intrinsic resistance to etoposide.
Open the PDF for in another window
Effects of modulators of protein kinases on taxol-induced apoptosis of human leukemic cells possessing disparate levels of p26BCL-2 protein.
V Ponnathpur; A M Ibrado; J C Reed; S Ray; Y Huang; S Self; G Bullock; A Nawabi; K Bhalla
View articletitled, Effects of modulators of protein kinases on taxol-induced apoptosis of human leukemic cells possessing disparate levels of p26BCL-2 protein.
Open the PDF for in another window
Pretreatment p53 protein expression correlates with decreased survival in patients with end-stage head and neck cancer.
E R Sauter; J A Ridge; S Litwin; C J Langer
View articletitled, Pretreatment p53 protein expression correlates with decreased survival in patients with end-stage head and neck cancer.
Open the PDF for in another window
Enhanced erbB-3 expression in human pancreatic cancer correlates with tumor progression.
H Friess; Y Yamanaka; M S Kobrin; D A Do; M W Büchler; M Korc
View articletitled, Enhanced erbB-3 expression in human pancreatic cancer correlates with tumor progression.
Open the PDF for in another window
Elevated levels of 2',5'-linked oligoadenylate-dependent ribonuclease L occur as an early event in colorectal tumorigenesis.
L Wang; A Zhou; S Vasavada; B Dong; H Nie; J M Church; B R Williams; S Banerjee; R H Silverman
View articletitled, Elevated levels of 2',5'-linked oligoadenylate-dependent ribonuclease L occur as an early event in colorectal tumorigenesis.
Open the PDF for in another window
Overexpression of insulin receptor substrate 1 (IRS-1) in the human breast cancer cell line MCF-7 induces loss of estrogen requirements for growth and transformation.
E Surmacz; J L Burgaud
View articletitled, Overexpression of insulin receptor substrate 1 (IRS-1) in the human breast cancer cell line MCF-7 induces loss of estrogen requirements for growth and transformation.
Open the PDF for in another window

Advertisement

Latest News
How Unruly DNA Loops Are Shaping Cancer—and Treatments
Global Platform Delivering Kids’ Cancer Drugs to Countries in Need
Cancer Grand Challenges Throws Down Gauntlet
View more recent articles
Breaking
pNET/epNET Drug Gets Thumbs Up
Ovarian Cancer Trial Brought to a Halt
New Nominee for CDC Director Named
View more recent articles
Research Watch
Synonymous Mutations in m6A-modified Sites Can Destabilize Tumor Suppressors
MIF–ACKR3 Signaling Drives Cancer Cachexia by Impairing Adipogenesis
Epithelial-to-Mesenchymal Transition Supports Pancreatic Cancer Evolution
View more recent articles

NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck.  None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.

  • Online ISSN 1557-3265
  • Print ISSN 1078-0432

AACR Journals

 

 

  • Copyright © 2025 by the American Association for Cancer Research.
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.
Accept